Study Designed to Assess the Safety, Tolerability and PK of PTI-808 in Healthy Volunteers and in Adults With Cystic Fibrosis January 31, 2019https://clinicaltrials.gov/ct2/show/study/NCT03251092 [Read more…] about Study Designed to Assess the Safety, Tolerability and PK of PTI-808 in Healthy Volunteers and in Adults With Cystic Fibrosis
Safety, Tolerability, and Pharmacokinetics of PTI-808, PTI-801, and PTI-428 Combination Therapy in Subjects With Cystic Fibrosis January 30, 2019https://clinicaltrials.gov/ct2/show/NCT03500263
